| Literature DB >> 30425060 |
Holly A Cyphert1, Emily M Walker1, Yan Hang1, Sangeeta Dhawan2, Rachana Haliyur1,3, Lauren Bonatakis1, Dana Avrahami4, Marcela Brissova1,3, Klaus H Kaestner5, Anil Bhushan6, Alvin C Powers1,3,7, Roland Stein8.
Abstract
The sustained expression of the MAFB transcription factor in human islet β-cells represents a distinct difference in mice. Moreover, mRNA expression of closely related and islet β-cell-enriched MAFA does not peak in humans until after 9 years of age. We show that the MAFA protein also is weakly produced within the juvenile human islet β-cell population and that MafB expression is postnatally restricted in mouse β-cells by de novo DNA methylation. To gain insight into how MAFB affects human β-cells, we developed a mouse model to ectopically express MafB in adult mouse β-cells using MafA transcriptional control sequences. Coexpression of MafB with MafA had no overt impact on mouse β-cells, suggesting that the human adult β-cell MAFA/MAFB heterodimer is functionally equivalent to the mouse MafA homodimer. However, MafB alone was unable to rescue the islet β-cell defects in a mouse mutant lacking MafA in β-cells. Of note, transgenic production of MafB in β-cells elevated tryptophan hydroxylase 1 mRNA production during pregnancy, which drives the serotonin biosynthesis critical for adaptive maternal β-cell responses. Together, these studies provide novel insight into the role of MAFB in human islet β-cells.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30425060 PMCID: PMC6341297 DOI: 10.2337/db18-0903
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461